Et Control

FDA Premarket Approval P210018

Pre-market Approval Supplement Details

DeviceEt Control
Generic NameSoftware Option For Anesthesia Gas Machine To Achieve And Maintain Targeted End Tidal Oxygen And Anesthetic Agents
ApplicantDatex-Ohmeda, Inc., A General Electric Companyp.o. Box 7550madison, WI 53707-7550 PMA NumberP210018 Date Received05/03/2021 Decision Date03/17/2022 Product Code QSF  Advisory Committee Anesthesiology Clinical TrialsNCT02972892 Expedited Review Granted? No
Date Received2021-05-03
Decision Date2022-03-17
PMAP210018
SupplementS
Product CodeQSF 
Advisory CommitteeAnesthesiology
Expedited ReviewNo
Combination ProductNo
Applicant AddressDatex-Ohmeda, Inc., A General Electric Company
p.o. Box 7550
madison, WI 53707-7550 PMA NumberP210018 Date Received05/03/2021 Decision Date03/17/2022 Product Code QSF  Advisory Committee Anesthesiology Clinical TrialsNCT02972892
Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval For Et Control Indicated For Use With The Datex-Ohmeda Aisys CS2 Anesthesia System To Support Clinicians In Maintaining The Targeted End Tidal Oxygen And End Tidal Anesthetic Agent Concentrations That The Clinician Sets During An Anesthetic Procedure, By Making Multiple, Limited Adjustments To The Fresh Gas Composition And Total Flow. The Et Control Feature Is Indicated For Adult Patients, 18 Years Of Age And Older.The Aisys CS2 Anesthesia System And The Et Control Feature Are Intended For Prescription Use Only. Supplements:  

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 133

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 133
Function: _error_handler

Supplement NumberDateSupplement Type
P210018Original Filing

NIH GUDID Devices

Device IDPMASupp
00195278579157 P210018 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.